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Abstract Two 4-amino-1,2,4-triazoles and two 1,3,4-oxadiazoles are 15 
obtained in a common synthetic route including hydrogenation-16 
hydrazidation of (Z)-methyl octadec-9-enoate to octadecanoic hydrazide 7 17 
under atmospheric air. Preservation of olefinic bond in heptadec-8-enyl 18 
group is achieved by carrying out hydrazidation reaction under the presence 19 
of an argon atmosphere. The disappearance of the olefinic bond is detected 20 
by physical data, IR, 1H-, and13C-NMR spectroscopy. New palladium 21 
complexes derived from 4-amino-5-heptadecyl-1,2,4-triazole-3-thiol and 5-22 
heptadecyl-1,3,4-oxadiazole-2(3H)-thione are obtained and characterized by 23 
elemental analysis (solid state), IR, 1H-, 13C-NMR spectroscopy, XRD and 24 
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 2 
XPS. These resulting metallic entities are also identified in solution based in 1 
mass spectrometry (MS-ESI) experiments. Most compounds and their 2 
palladium(II) complexes are tested in vitro against Gram-positive, Gram-3 
negative bacteria and fungi, some of them showed variable activity. 4 
 5 
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Graphical Abstract 1 
 2 
 3 
Introduction 4 
Saturated and unsaturated fats and their saturated and unsaturated fatty acids 5 
have been the concern of many chemists and biologists since a long time 6 
because of their advantages and disadvantages to health of human beings via 7 
his dietary [1-6]. The importance of fatty acids in membrane function has 8 
been reinforced by observations that their deficiencies in brain and retinal 9 
tissues can result in compromised visual acuity [7], learning ability and even 10 
in neurologic problems [4,8]. Concerning the importance in protein function, 11 
each fatty acid has the disadvantage of involving non-physiological 12 
conditions of making it difficult to assess their functional significance. 13 
However, many review articles recommended a diet low in saturated fat and 14 
argue it will lower risks of cardiovascular diseases, diabetes or death [9,10]. 15 
Fatty acids have also industrial uses as fuels, surfactants [11,12] and 16 
catalysts [12]. Fatty acid derivatives such as branched chain-fatty acids and 17 
cyclic fatty acids have antibacterial effects [13]. Heterocyclic derivatives 18 
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form suitable precursors for nucleoside, nucleotides formations [14] and 1 
showed high tendency to form complexes with various metals. Some of these 2 
complexes have been used as efficient antibiotics [15] and as catalysts in 3 
many reactions such as Tsuji-Trost and Mizoroki-Heck [16]. 4 
Mobile oxidation or/and hydrogenation of unsaturated bond have bee 5 
also reported [17,18] as a case that involves a serious danger to human 6 
health, caused by food industry and synthetic works [19,20]. This 7 
observation of mobile reactional changes from unsaturated to saturated fatty 8 
acid prompted us to investigate a similar work under atmosphere of air and 9 
argon to preserve the double bond. 10 
In this article we studied the behavior of the employment of saturated 11 
and unsaturated fatty acids during the process to prepare two 4-amino-1,2,4-12 
triazoles and two 1,3,4-oxadiazoles through a common synthetic route. Also, 13 
preparation of palladium complexes from saturated amino-1,2,4-triazole and 14 
1,3,4-oxadiazole were considered. Biological activity were tested upon 15 
saturated heterocyclic products, their intermediates and their palladium(II) 16 
complexes. 17 
 18 
 19 
Results and Discussion 20 
Synthesis of heterocyclic compounds 5, 6, 9 and 10 21 
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Ester 2 of (Z)-octadec-9-enoic acid (1, oleic acid) have been prepared and 1 
identified by classical methods [16]. When ester 2 was treated with hydrazine 2 
hydrate (85%), under atmospheric oxygen, a non-catalytic hydrogenation-3 
hydrazination process took place (see Scheme 1) and octadecanoic hydrazide 4 
3 was exclusively obtained. The 1H-NMR spectrum did not show the olefinic 5 
protons indicating that the double bond was reduced by the hydrazine 6 
hydrate under atmospheric oxygen. This behavior was documented in the 7 
literature [21,22] (Scheme 2). Hydrazide 3 was transformed into 4-amino-5-8 
heptadecyl-1,2,4-triazole-3-thiol (5) and 5-heptadecyl-(3H)-1,3,4-9 
oxadiazole-2-thione (6) [16] as illustrated in Scheme 1. Structures of 10 
intermediates and heterocyclic products 5 and 6 were determined by IR, 1H-11 
NMR, 13C-NMR and MS. The selection of these heterocycles as suitable 12 
ligands of palladium(II) salts was carried out with the idea of improving the 13 
biological activity of the pure isolated heterocycles. 14 
However, when ester 2 was treated with hydrazine hydrate (99 %) 15 
under atmosphere of argon (using freezing-pump conditions before the 16 
mixture of the reagents) (Z)-octadec-9-ene hydrazide 7 was isolated. IR 17 
spectrum showed absorption at 1535 cm-1 indicating the presence of the 18 
olefinic bond, which was confirmed by 1H-NMR (multiplet at 5.35 ppm) and 19 
13C-NMR (signal at 129.84 ppm) (see Figures 1 and 2, basic lines). The salt 20 
8, (Z)-4-amino-5-heptadec-8-enyl-1,2,4-triazole-3-thiol (9) and (Z)-5-21 
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 6 
heptadec-8-enyl-1,3,4-oxadiazole-2(3H)-thione (10) were obtained by the 1 
known method [16] under argon atmosphere. Structural proof for 8-10 were 2 
provided by IR, 1H-NMR, 13C-NMR and MS data.  3 
 4 
 5 
 6 
Scheme 1: Synthetic route of heterocycles 5, 6, 9 and 10. 7 
 8 
 A plausible mechanism for the non-catalytic hydrogenation of the 9 
carbon-carbon double bond can be observed in Scheme 2. The easy oxidation 10 
and disproportionation of the hydrazine could contribute to the hydrogen 11 
transfer from the diimide to the olefin with the subsequent extrusion of 12 
nitrogen. This process is very fast and the presence of oxygen was crucial to 13 
enhance it.  14 
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 1 
Scheme 2: A proposed mechanism for non-catalytic hydrogenation-2 
hydrazination of 2 to 3. 3 
 4 
Stability of the olefinic bond in (Z)-octadec-9-enehydrazide (oleic hydrazide) 5 
7 6 
Such as it was mentioned earlier, (Z)-octadec-9-enehydrazide 7, prepared 7 
under atmosphere of argon, showed 1HNMR spectrum (basic line in Figure 8 
1) illustrating clearly the presence of olefinic bond at 5.35 ppm with an 9 
integration of two protons and about twenty paraffinic protons at 1.28 ppm. 10 
In addition, its 13CNMR spectra in Figure 2 showed a signal at 129.84 ppm 11 
for (C=C) (basic line in Figure 2).  12 
After the exposure to air, the olefinic and allylic protons diminished 13 
as illustrated at chemical shift positions at 5.35, 2.01 ppm, while integration 14 
of paraffinic protons at 1.29 ppm were increased by two protons (see upper 15 
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line in Figure 1). Also, 13C-NMR spectra in Figure 2 showed the 1 
disappearance of the signal at 129.84 ppm for (C=C). 2 
 3 
 4 
Figure 1. 1H-NMR spectra of oleic hydrazide 7 synthesized under 5 
atmosphere of argon (basic line) and after exposure to air (upper line). 6 
 7 
When the hydrazide 7 was kept for almost one year under atmosphere 8 
of argon, its 1H-NMR of 7 remained unaltered, but immediately diminished 9 
within few hours when compound 7 was exposed to air. Therefore, due to 10 
sensitivity of the olefinic bond in (Z)-octadec-9-ene hydrazide 7 and other 11 
products to air, no further application reactions neither complex formation 12 
-     Spectrum of 3 under atmosphere of air 
       Spectrum of 7 under atmosphere of argon 
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nor biological activity test were carried out with these unsaturated 1 
derivatives. 2 
 3 
 4 
Figure 2. 13C-NMR spectra of oleic hydrazide 7 under atmosphere of argon 5 
(in black line) and after exposure to air (in red line).  6 
 7 
Preparation of Palladium(II) complexes 11a, 11b, 12a, 12b 8 
Compounds 4-amino-5-heptadecyl-1,2,4-triazole-3-thiol (5) and 5-9 
heptadecyl-1,3,4-oxadiazole-2(3H)-thione (6) were treated individually with 10 
palladium salts, Pd(OAc)2 and K2PdCl4 at room temperature. In all cases, 11 
orange color solutions were obtained. The possible structures of complexes 12 
11a, 11b, 12a, 12b were very difficult to determine despite many 13 
 Spectrum of 3 under atmosphere of air 
  Spectrum of 7 under atmosphere of argon 
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spectroscopic data and microanalysis performed. For example, FTIR results 1 
showed that the disappearance of N-H in 11a, 11b and 12a and the 2 
delocalization of C=N absorption in IR is a clear evidence for the formation 3 
metallic palladium(II)-complexes. Similarly, the differences in 1H-NMR and 4 
13C-NMR between ligands 5 and 6 and their Pd-complexes 11a, 11b, 12a 5 
and 12b supported that structural arrangements occurred.  6 
XPS and XRD analysis were another instrumental techniques used for 7 
the characterization of these complexes (see SI). Mass spectra analysis also 8 
confirmed the presence of the dinuclear/dimeric structures using ESI, which 9 
was not determining.  10 
  11 
 12 
Scheme 3: Synthesis of Pd-complexes 11a, 11b, 12a and 12b. 13 
 14 
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We have studied X-ray powder diffraction (XRD) of two resulting 1 
complexes (11b and 12a) using K2PdCl4 and Pd(OAc)2 palladium sources 2 
(see SI). Resulting spectra showed intense Bragg’s reflections related to the 3 
palladium which are very similar to PdCl2 or (NH)4PdCl2 pattern [23,24] 4 
confirming presence of palladium(II) species in complexes structure. 5 
The reported X-ray diffraction analysis of similar triazol-6 
palladium(II) complexes did not provide an uniform trend for these 7 
complexes and are not helpful to determine the exact nature of complexes 11 8 
and 12. Thus, a dinuclear structure with strong S-Pd coordination [25], a 9 
dinuclear paddle-wheel structure incorporating phosphines as ligands [26], 10 
mono- and binuclear complexes with S-Pd-N coordination [27], etc. In 11 
similar way, oxadiazole-2-thiones formed complexes with palladium(II) 12 
salts and stabilizing phosphines to give mononuclear complexes with two 13 
units of the heterocyclic moiety [28], mononuclear species with two 14 
heterocyclic ligands [29], homobinuclear complexes [30], etc.   15 
Palladium(II) complexes for ligands 9 and 10 had not been performed 16 
due to the fact that mobility of the olefinic bond in them may affected by Pd 17 
ions and atmospheric oxygen during synthetic and structural determination 18 
times. 19 
 20 
Antimicrobial Activity: 21 
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(Z)-octadec-9-enoic acid (oleic acid) (1), the ester 2, octadecanehydrazide 1 
(3), 4-amino-5-heptadecyl-1,2,4-triazole-3-thiol (5) and 5-heptadecyl-1,3,4-2 
oxadiazole-2(3H)-thione (6) and palladium(II)-complexes 11a, 11b, 12a, 3 
12b, were tested in vitro against eight strains, Gram positive bacteria 4 
Staphylococcus aureus (ATCC 25923), Staphylococcus aureus laboratory 5 
isolate, Enterococcus faecalis (ATCC 29212), Gram negative bacteria, 6 
Escherichia coli (ATCC 25922), Pseudomonas aeruginosa (ATCC 27853), 7 
and fungus Aspergillus niger, Candida albicans, Trichosporon. 8 
Vancomycin, colistin were used as positive references and DMSO as 9 
negative reference. Results are summarized in Tables 1, 2 and 3. Table 1 10 
showed that 4-amino triazole 5 had significant effect upon Gram positive, 11 
Gram negative bacteria and one fungus Candida albicans. There are cases 12 
when ligand 5 against Gram positive Staphylococcus aureus (ATCC 25923) 13 
and Gram-negative Escherichia coli (ATCC 25922), exceeded the 14 
references, whilst oxadiazole 6 was effective against Gram positive bacteria 15 
only. Pd-complexes of amino triazole 11a and 11b and Pd-complex of 16 
oxadiazole 12a were almost ineffective against Gram positive, Gram 17 
negative bacteria nor fungus due to the powerful attachment of ligand-Pd 18 
[22]. Only compounds active in this primary screening were further tested in 19 
a second set of dilution 5-𝜇g (cm3)-1 and downward against all 20 
microorganisms as shown in Table 3. 21 
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 1 
Table 1. Antimicrobial activity of synthesized compounds [10 mg (cm3)-1], 2 
zone inhibition in mm. 3 
 
Comp. 
 
G(+) bacteria 
 
G(-) bacteria 
 
Fungi 
i ii iii iv v vi vii viii 
1 - 8 - - - - - - 
2 7 9 - 7 - - - - 
3 - - - - - - - - 
5 29 15 19 22 34 - 10 - 
11a - - - - - - - - 
11b - - - - - - - 10 
6 12 14 9 - - - - - 
12a - - - - 7 - - - 
12b 7 12 - 7 11 - - - 
Control DMSO - - - - - - - - 
Vancomycin 18 30 23 - - - - - 
Colistin - - - 14 11 - - - 
(-): Inactive, no inhibition zone 4 
i: Staphylococcus aureus (ATCC 25923), ii: Staphylococcus aureus 5 
laboratory isolate, iii: Enterococcus faecalis (ATCC 29212), iv : Escherichia 6 
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coli (ATCC 25922), v: Pseudomonas aeruginosa (ATCC 27853), vi: 1 
Aspergillusniger, vii: Candida albicans, viii: Trichosporon 2 
 3 
Table 2: The minimal inhibitory concentrations [MIC, mg/(cm3)-1] data 4 
 
Comp. 
G(+) bacteria G(-) bacteria 
i ii iii iv v 
1 - - - - - 
2 - - - - - 
3 - - - - - 
5 C/2 C/2  C/4 C/4 
11a - - - - - 
11b - - - - - 
6 C/4 C/4 - - - 
12a - - - - - 
12b - - - - - 
 5 
C/2=5 mg¸ C/4=2.5 mg¸ C/8 = 1.25 mg¸ C/16 = 0.625 mg. 6 
 7 
Table 3. Bacteriostatic and bactericidal tests. 8 
Comp. i ii iii iv v 
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11 bacteriostatic bacteriostatic - bacteriostatic bacteriostatic 
12 bacteriostatic bacteriostatic - - - 
 1 
 2 
 3 
Conclusions. 4 
During our attempt to synthesize diazole derivatives from unsaturated fatty 5 
acid, (Z)-octadec-9-enoic acid (1, oleic acid) was noticed that during 6 
hydrazination step, under normal conditions of atmosphere of air, the 7 
olefinic bond had been subjected to internal hydrogenation. When the same 8 
hydrazination reaction was repeated under atmospheric pressure of argon, 9 
the olefinic bond kept intact. It was found also that the double bond was kept 10 
as it for a long time -up to one year- under storage under atmosphere of argon 11 
and gradually diminished after the exposition to air at any stage of reaction 12 
after hydrazination. Therefore, the synthesis of 4-amino-5-heptadecyl-1,2,4-13 
triazole-3-thiol (5) and 5-heptadecyl-1,3,4-oxadiazole-2(3H)-thione (6) 14 
were carried out under atmosphere of air and for (Z)-4-amino-5-heptadec-8-15 
enyl-1,2,4-triazole-3-thiol (9) and (Z)-5-heptadec-8-enyl-1,3,4-oxadiazole-16 
2(3H)-thione (10) were achieved under atmosphere of argon. Ligands 5 and 17 
6 showed a tendency to form stable Pd-complexes 11a, 11b, 12a and 12b 18 
possessing a weak biological activity.  19 
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 1 
 2 
Experimental  3 
General 4 
All chemicals were purchased from Acros, Alpha, or Sigma-Aldrich and 5 
used without further purification. Compounds 2-10 are known compounds 6 
(see above).[31] Melting points were determined with a Reichert Thermowar 7 
hot plate apparatus and are uncorrected. Only the structurally most important 8 
peaks of the IR spectra (recorded with a FT-IR 4100LE (JASCO) (PIKE 9 
MIRacle ATR) are listed. 1 HNMR (300, 400 MHz or 500 MHz) and 13C-10 
NMR (75, 101 or 126 MHz) spectra were recorded using Bruker AV300, 11 
Bruker AV400 and Bruker ADVANCE DRX500, with CDCl3 as solvent and 12 
TMS as internal standard and chemical shifts are given in ppm. Low-13 
resolution electron impact (GC-EI) mass spectra were obtained at 70 eV 14 
using an Agilent 6890N Network GC system and Agilent 5973Network 15 
Mass Selective Detector. Microanalyses were performed in a Thermo 16 
Finnigan Flash 1112 series. TLC was performed on Schleicher & Schuell 17 
F1400/LS 254 silica gel plates and the spots were visualized under UV light 18 
(λ = 254 nm). Merck silica gel 60 (0.040–0.063 mm) was used for flash 19 
chromatography. 20 
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Microorganisms in this study were supplied and identified by the 1 
laboratory of microbiology by the university hospital of Oran. The Mueller 2 
Hinton medium was supplied by (Difco). 3 
 4 
Methyl (Z)-heptadec-9-enoate (methyl oleate) 2:[32] 5 
 6 
Stearohydrazide 3: mp: 140 °C (from EtOH); lit. 140-143 (form 7 
dioxane/hexane).[31a] 8 
 9 
4-Amino-5-heptadecyl-4H-1,2,4-triazole-3-thiol 5: mp: 102 °C (from 10 
hexanes/ethyl acetate); lit. 98-105 ºC (from MeOH/water).[33]  11 
 12 
5-Heptadecyl-(1,3,4)-oxadiazole-2(3H)-thione 6: mp: 88 °C (from 13 
chloroform/EtOH); lit. 90-91 ºC (from EtOH/water) [31a] 14 
 15 
Oleohydrazide 7: mp:  40 °C (from EtOH); lit. 36-39 ºC (from EtOH). [34]  16 
 17 
(Z)-4-Amino-5-(heptadec-8-en-1-yl)-4H-1,2,4-triazole-3-thiol 9: mp: 79 °C 18 
(from ethyl acetate); lit. 76-77 ºC (from ethyl acetate). [31b] 19 
 20 
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(Z)-5-(Heptadec-8-en-1-yl)-1,3,4-oxadiazole-2(3H)-thione 10: mp: 90 °C; 1 
lit. 87-89 ºC (from EtOH). [31b] 2 
 3 
Synthesis of the palladium(II) complexes (11) and (12). The complexes were 4 
prepared individually by adding (0.011mol) of ligands 5 or 6 in 10 cm3  of 5 
chloroform to a solution of palladium salt [Pd(OAc)2 or K2PdCl4 ] (0.01mol) 6 
in the same solvent (10 cm3) and stirring the solutions at room temperature 7 
for 24 hours, orange color solutions were obtained.  Complexes were 8 
collected after, the solvents were evaporated, washed with methanol and 9 
dried under vacuum.  10 
 11 
(11a): Brown powder, mp >300 ºC (from methanol/water). IR υmax (cm-1): 12 
1609, 1313. 1H NMR δH (ppm): 0.87 (t, 6H, 2xCH3), 1.48 (m, 60H, 30xCH2), 13 
2.04 (m, 4H, 2xNH2) 2.68 (m, 4H, 2xCH2CN). 
13C NMR, δC (ppm):  13.8 14 
(2xCH3), 22.8 (m, 32xCH2),
 156.1 (2xNC=O), 168.1 (2xCS). MS-ESI (m/z): 15 
965 [L2Pd2H2O(MeCN)2+1]. Microanalysis required for C38H74N8PdS2: C 16 
56.1, H 9.2, N 13.8; found: C 55.8, H 9.4, N 13.8%. 17 
 18 
(11b): Brown powder, mp 274-279 ºC (from methanol/water). IR υmax (cm-19 
1): 1606, 1213. 1H NMR δH (ppm):  0.87 (t, 6H, 2xCH3), 1.27 (m, 60H, 20 
30xCH2), 1.67 (m, 4H, 2xNH2); 2.70 (m, 4H, 2xCH2CN). 
13C NMR δC 21 
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(ppm): 14.1 (2xCH3), 31.0 (m, 32xCH2), 158.0 (2xNC=O), 165.3 (2xCS).  1 
MS-ESI (m/z): 712.5 (L2Pd2Cl2·MeCN-(CH2)16-CH3+1). Microanalysis 2 
required for C38H74Cl2N8Pd2S2: C 46.1, H 7.5, N 11.3; found: C 45.7, H 7.5, 3 
N 11.1%. 4 
 5 
(12a): Brown sticky powder, mp >300 ºC (from methanol/water). IR υmax 6 
(cm-1): 1597, 1185. 1H NMR δH (ppm): 0.87 (t, 6H, 2xCH3), 1.25 (s, 56H, 7 
28CH2); 1.68 (m, 4H, 2xCH2CH2CN), 2.65 (m, 4H, 2xCH2CN). 
13C NMR, 8 
δC (ppm):   14.1 (2xCH3), 30.0 (m, 32xCH2), 168.2 (2xNC=O), 178.7 9 
(2xC=S). MS-ESI (m/z): 993 [L2Pd2(H2O)(MeCN)2+1]. Microanalysis 10 
required for C38H70N4O2PdS2: C 58.1, H 9.0, N 7.1; found: C 57.8, H 8.7, 11 
N 7.0%. 12 
 13 
(12b): Brown sticky solid, mp >300. IR υmax (cm-1): 3219, 1678, 1185. 14 
1H NMR δH (ppm): 0.88 (t, 6H, 2xCH3), 1.29 (m, 56H, 28xCH2), 1.67 (m, 15 
4H, 2xCH2CH2), 2.66 (m, 4H, 2xCH2). 
13C NMR, δC (ppm): 14.1 (2xCH3), 16 
28.5 (32xCH2), 168.2 (2xNC=O), 179.5 (2xC=S). MS-ESI (m/z): 960 17 
(L2Pd2Cl2). Microanalysis required for C38H70Cl2N4O2Pd2S2: C 47.4, H 7.3, 18 
N 5.8; found: C 47.0, H 7.7, N 5.6. 19 
 20 
Antibacterial and anti fungal activity: 21 
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 The respective different strain was spread separately on the Mueller-1 
Hinton for antibacterial activity (CLSI 2004; CLSI 2012). Then the test 2 
organism suspension was added and incubated at 37 ºC for 24 h for bacteria 3 
studies. The drugs collystin and vancomycin were taken as standard drug to 4 
compare the results and dimethylsulfoxide (DMSO) was taken as blank [35]. 5 
Bacteriostatic or bactericide test was determined as follows: a small sample 6 
was taken from each well where there was no visible growth, using an 7 
inoculation loop, which was then spread on GN plates and incubated 8 
overnight at 37°C [36]. The minimum inhibitory concentration (MIC) was 9 
the lowest concentration of test compound that inhibit the visible growth of 10 
the organism and was determined in triplicates [37]. 11 
 12 
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Figure and Scheme Captions 12 
 13 
Scheme 1: Synthetic route of heterocycles 5, 6, 9 and 10. 14 
 15 
Scheme 2: A proposed mechanism for non-catalytic hydrogenation of 2. 16 
 17 
Scheme 3: Synthesis of Pd-complexes 11a, 11b, 12a and 12b. 18 
 19 
Figure 1. 1HNMR spectra of oleic hydrazide 7 synthesized under 20 
atmosphere of argon (basic line) and after exposure to air (upper line). 21 
 22 
Figure 2. 13CNMR spectra of oleic hydrazide 7 under atmosphere of argon 23 
(in black line) and after exposure to air (in red line).  24 
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 3 
Table 1. Antimicrobial activity of synthesized compounds [10 mg/(cm3)-1], 4 
zone inhibition in mm. 5 
 
Comp. 
G(+) 
bacteria 
G(-) bacteria  
Fungi 
i ii iii iv v vi vii viii 
1 - 8 - - - - - - 
2 7 9 - 7 - - - - 
3 - - - - - - - - 
5 29 15 19 22 34 - 10 - 
11a - - - - - - - - 
11b - - - - - - - 10 
6 12 14 9 - - - - - 
12a - - - - 7 - - - 
12b 7 9 - 7 11 - - - 
Control DMSO - - - - - - - - 
Vancomycin 18 30 23 - - - - - 
Colistin - - - 14 11 - - - 
 6 
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 3 
 4 
Table 2: The minimal inhibitory concentrations (MIC, mg/mL) data 5 
 
Comp. 
G(+) bacteria G(-) bacteria 
i ii iii iv v 
1 - - - - - 
2 - - - - - 
3 - - - - - 
5 C/2 C/2  C/4 C/4 
11a - - - - - 
11b - - - - - 
6 C/4 C/4 - - - 
12a - - - - - 
12b - - - - - 
                 C/2=5 mg¸ C/4=2.5 mg¸ C/8 = 1.25 mg¸ C/16 = 0.625 mg. 6 
 7 
Table 3. Bacteriostatic and bactericidal tests. 8 
Comp. i ii iii iv v 
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11 bacteriostatic bacteriostatic - bacteriostatic bacteriostatic 
12 bacteriostatic bacteriostatic - - - 
 1 
 2 
 3 
Scheme 1: Synthetic route of heterocycles 5, 6, 9 and 10. 4 
 5 
 6 
Scheme 2: A proposed mechanism for non-catalytic hydrogenation of 2. 7 
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Scheme 3: Synthesis of Pd-complexes 11a, 11b, 12a and 12b. 3 
 4 
 5 
 6 
 7 
Graphical Abstract 8 
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